London, 31 December 2014: TechNavio, the independent tech-focused global research firm, has published a report on the Global Neurosurgery Market 2015-2019, which is expected to grow at a CAGR of 11.71 percent during the period 2014-2019.
With an increase in the launch of products, trained healthcare professionals to operate the sophisticated equipment, and collaborations among vendors, the market is expected to witness significant growth. Moreover, the increasing prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, and Parkinson’s disease, as well as the popularity of navigation with multimodality imaging are expected to contribute significantly to the growth of the market.
“Neurostimulation devices are used in the treatment of epilepsy, migraines, post-cancer therapy pain, lower back pain, chronic pain, and Parkinson’s disease,” says Faisal Ghaus, Vice President of TechNavio.
“The clinical evidence supporting the use of neurostimulation devices is increasing its adoption rate among neurosurgeons.”
Key Market Drivers
- Increase in Prevalence of Neurological Disorders
- Advances in Technology
- Increase in Demand for MI Neurosurgeries
- Increase in Aging Population
- Rise in Awareness in US
Key Market Trends
- Increased Adoption of Neurostimulation Devices
- Increase in Use of Frameless Stereotaxy
- Growing Popularity of Awake Craniotomy
Key Market Vendors
- Codman & Shurtleff Inc.
- Integra LifeSciences Corp.
- Medtronic Inc.
- Stryker Corp.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
